Pd-1 Antibody Combined CCRT for Local Advanced Cervical Cancer.

NCT04368273 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: PD-1 antibody

Sponsor

Peking University Third Hospital